Use of Rituximab in a Sjogren's Disease-Associated Inflammatory Pseudotumor: A Case Report. (PubMed, Case Rep Rheumatol) - Sep 27, 2026 - "She was then initiated on rituximab, resulting in an excellent clinical outcome and continued shrinkage of the pseudotumor. This case suggests that rituximab is a possible consideration in the treatment of SjD-related inflammatory pseudotumors and inflammatory arthralgias, especially when continuous corticosteroid therapy is not ideal."
Journal • Back Pain • Lung Cancer • Musculoskeletal Pain • Oncology • Pain • Sjogren's Syndrome
|
|
Lewis Wesselius; Melissa Stanton; Staci Beamer; Tanya Rath; Vivek Nagaraja; Vivian Shing
|